Literature DB >> 17301120

Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.

Masahiko Yokoi1, Sho-ichi Yamagishi, Akari Saito, Yumiko Yoshida, Takanori Matsui, Wataru Saito, Shigeki Hirose, Kazuhiro Ohgami, Manabu Kase, Shigeaki Ohno.   

Abstract

BACKGROUND: Pigment epithelium-derived factor (PEDF), a glycoprotein with potent neuronal differentiating activity, was recently found to inhibit advanced glycation end product (AGE)-induced retinal hyperpermeability and angiogenesis through its antioxidative properties, suggesting that it may exert beneficial effects on diabetic retinopathy by acting as an endogenous antioxidant. However, the inter-relationship between PEDF and total antioxidant capacity in the eye remains to be elucidated. AIMS: To determine vitreous PEDF and total antioxidant levels in patients with proliferative diabetic retinopathy (PDR), and to investigate the relationship between them.
METHODS: Vitreous levels of PEDF and total antioxidant capacity were measured by an ELISA in 39 eyes of 36 patients with diabetes and PDR and in 29 eyes of 29 controls without diabetes.
RESULTS: Vitreous levels of total antioxidant capacity were significantly lower in patients with diabetes and PDR than in controls (mean (SD) 0.16 (0.05) vs 0.24 (0.09) mmol/l, respectively, p<0.001). PEDF levels correlated positively with total antioxidant status in the vitreous of patients with PDR (r = 0.37, p<0.05) and in controls (r = 0.41, p<0.05). Further, vitreous levels of PEDF in patients with PDR without vitreous haemorrhage (VH(-)) were significantly (p<0.05) decreased, compared with those in the controls or in patients with PDR with vitreous haemorrhage (VH(+); PDR VH(-), 4.5 (1.1) microg/ml; control, 7.4 (4.1) microg/ml; PDR VH(+) 8.5 (3.6) microg/ml).
CONCLUSION: This study demonstrates that PEDF levels are associated with total antioxidant capacity of vitreous fluid in humans, and suggests that PEDF may act as an endogenous antioxidant in the eye and could play a protective role against PDR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301120      PMCID: PMC1955675          DOI: 10.1136/bjo.2006.110890

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity.

Authors:  J Tombran-Tink; G G Chader; L V Johnson
Journal:  Exp Eye Res       Date:  1991-09       Impact factor: 3.467

2.  Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy.

Authors:  B O Boehm; G Lang; O Volpert; P M Jehle; A Kurkhaus; S Rosinger; G K Lang; N Bouck
Journal:  Diabetologia       Date:  2003-03-01       Impact factor: 10.122

3.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

4.  Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.

Authors:  Shinjiro Amano; Sho-Ichi Yamagishi; Yosuke Inagaki; Kazuo Nakamura; Masayoshi Takeuchi; Hiroyoshi Inoue; Tsutomu Imaizumi
Journal:  Microvasc Res       Date:  2005-01       Impact factor: 3.514

5.  Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy.

Authors:  M Yokoi; S-I Yamagishi; M Takeuchi; K Ohgami; T Okamoto; W Saito; M Muramatsu; T Imaizumi; S Ohno
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

6.  Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells.

Authors:  S Yamagishi; T Matsui; H Inoue
Journal:  Drugs Exp Clin Res       Date:  2005

7.  Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.

Authors:  Elia J Duh; Hoseong S Yang; Izumi Suzuma; Masaru Miyagi; Elaine Youngman; Keisuke Mori; Miyuki Katai; Lin Yan; Kiyoshi Suzuma; Karen West; Shekar Davarya; Patrick Tong; Peter Gehlbach; Joel Pearlman; John W Crabb; Lloyd P Aiello; Peter A Campochiaro; Donald J Zack
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

8.  Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.

Authors:  Sho-ichi Yamagishi; Kazuo Nakamura; Takanori Matsui; Yosuke Inagaki; Katsuhiko Takenaka; Yuko Jinnouchi; Yumiko Yoshida; Tetsuro Matsuura; Isao Narama; Yoshihiro Motomiya; Masayoshi Takeuchi; Hiroyoshi Inoue; Akihiko Yoshimura; Richard Bucala; Tsutomu Imaizumi
Journal:  J Biol Chem       Date:  2006-05-17       Impact factor: 5.157

9.  Changes in IGF activities in human diabetic vitreous.

Authors:  Clyde Guidry; Richard Feist; Robert Morris; Charles W Hardwick
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

10.  Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome.

Authors:  Sho-Ichi Yamagishi; Hisashi Adachi; Akio Abe; Takako Yashiro; Mika Enomoto; Kumiko Furuki; Asuka Hino; Yuko Jinnouchi; Katsuhiko Takenaka; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi
Journal:  J Clin Endocrinol Metab       Date:  2006-03-07       Impact factor: 5.958

View more
  14 in total

Review 1.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 2.  Optical quality of the diabetic eye: a review.

Authors:  A M Calvo-Maroto; R J Perez-Cambrodí; C Albarán-Diego; A Pons; A Cerviño
Journal:  Eye (Lond)       Date:  2014-08-15       Impact factor: 3.775

3.  Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy.

Authors:  Nader Sheibani; Ismail S Zaitoun; Shoujian Wang; Soesiawati R Darjatmoko; Andrew Suscha; Yong-Seok Song; Christine M Sorenson; Victor Shifrin; Daniel M Albert; Ignacio Melgar-Asensio; Irawati Kandela; Jack Henkin
Journal:  Exp Eye Res       Date:  2020-04-06       Impact factor: 3.467

4.  Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Sho-Ichi Yamagishi
Journal:  J Ophthalmol       Date:  2010-06-22       Impact factor: 1.909

5.  Intra-ocular expression of vascular endothelial growth factor (VEGF) and pigment epithelial-derived factor (PEDF) in a case of Eales' disease by immunohistochemical analysis: a case report.

Authors:  Aditya Verma; Jyotirmay Biswas; Selvi Radhakrishnan; Angayarkanni Narayanasamy
Journal:  Int Ophthalmol       Date:  2010-01-05       Impact factor: 2.031

Review 6.  The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease.

Authors:  Siva S R Iyer; Mollie K Lagrew; Stephanie M Tillit; Ramak Roohipourmoallai; Samuel Korntner
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

7.  Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.

Authors:  Ahmed M Abu El-Asrar; Mohd Imtiaz Nawaz; Dustan Kangave; Mohammed Mairaj Siddiquei; Karel Geboes
Journal:  Mediators Inflamm       Date:  2012-09-29       Impact factor: 4.711

8.  Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease.

Authors:  Narayanasamy Angayarkanni; Radhakrishnan Selvi; Rishi Pukhraj; Jyotirmoy Biswas; Shah J Bhavesh; Joyce Tombran-Tink
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-06

9.  Antioxidant Status in the Vitreous of Eyes with Rhegmatogenous Retinal Detachment with and without Proliferative Vitreoretinopathy, Macular Hole and Epiretinal Membrane.

Authors:  Agata Pietras-Baczewska; Katarzyna Nowomiejska; Agnieszka Brzozowska; Mario Damiano Toro; Wojciech Załuska; Małgorzata Sztanke; Krzysztof Sztanke; Robert Rejdak
Journal:  Life (Basel)       Date:  2021-05-19

10.  PEDF in diabetic retinopathy: a protective effect of oxidative stress.

Authors:  Xiao-feng Zhu; Hai-dong Zou
Journal:  J Biomed Biotechnol       Date:  2012-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.